December 8, 2021
PAR-22-028 - Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a correction to the due dates for Funding Opportunity Announcement (FOA) PAR-22-028, "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)". The final due date period for this FOA will be June 1, 2024 to September 30, 2024. This FOA will expire on October 1, 2024. Changes to the FOA are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates:
Application Due Date(s)
December 22, 2021 - January 31, 2022
February 1, 2022 - May 31, 2022
June 1, 2022 - September 30, 2022
October 1, 2022 - January 31, 2023
February 1, 2023 - May 31, 2023
June 1, 2023 - September 30, 2023
October 1, 2023 - January 31, 2024
February 1, 2024- May 31, 2024
June 1, 2024 - September 31, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
March 2022, July 2022, November 2022, March 2023, July 2023, November 2023, March 2024, July 2024, November 2024
Advisory Council Review
May 2022; October 2022; January 2023; May 2023; October 2023; January 2024; May 2024; October 2024; January 2025
Earliest Start Date
June 2022, November 2022, February 2023, June 2023, November 2023, February 2024, June 2024, November 2024, February 2025
Expiration Date
October 01, 2024
Due Dates for E.O. 12372
Not Applicable
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Key Dates:
Application Due Date(s)
December 22, 2021 - January 31, 2022
February 1, 2022 - May 31, 2022
June 1, 2022 - September 30, 2022
October 1, 2022 - January 31, 2023
February 1, 2023 - May 31, 2023
June 1, 2023 - September 30, 2023
October 1, 2023 - January 31, 2024
February 1, 2024- May 31, 2024
June 1, 2024 - September 30, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
March 2022, July 2022, November 2022, March 2023, July 2023, November 2023, March 2024, July 2024, November 2024
Advisory Council Review
May 2022; October 2022; January 2023; May 2023; October 2023; January 2024; May 2024; October 2024; January 2025
Earliest Start Date
June 2022, November 2022, February 2023, June 2023, November 2023, February 2024, June 2024, November 2024, February 2025
Expiration Date
October 01, 2024
Due Dates for E.O. 12372
Not Applicable
All other aspects of this FOA remain unchanged.
Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]
and Human Services (HHS)
